MeSH tree: D27.505.696.477
Researchers at the University of Oslo and Oslo University Hospital, together with international collaborators, have discovered that a small molecule made exclusively by gut bacteria can actively drive disease in the bile ...
Sep 4, 2026
0
38
Outfitting cells in "invisibility cloaks" may offer an easier, less damaging treatment pathway for people with diabetes undergoing cell therapy, according to researchers at Penn State.
Aug 14, 2026
0
37
UCLA researchers have identified a promising strategy to make a new class of targeted cancer therapies more effective against one of the deadliest forms of prostate cancer, potentially overcoming treatment resistance that ...
Aug 4, 2026
0
10
Researchers at the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center are zeroing in on less toxic and more targeted strategies to combat Ewing sarcoma, an aggressive and rare pediatric cancer that develops ...
Aug 4, 2026
0
5
A team led by researchers from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute has discovered a promising new approach to treating advanced colorectal cancer. The study, published in Nature, identifies ...
Jul 1, 2026
0
6
A drug commonly used to treat epilepsy could be repurposed to significantly boost the response to vaccines in humans, helping protect those for whom the vaccine is less effective, such as older adults or immunocompromised ...
Jun 30, 2026
0
6
Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, have found a link between a bacterium in the gut microbiome (ecosystem) and lupus that could lead to more effective ...
Jun 25, 2026
0
33
A new treatment that involves growing a patient's immune cells and then infusing them back into their body has shown promise for people with the rare blood disorder aplastic anemia. Results from the Phase 1 trial, led by ...
Jun 11, 2026
0
9
A major real-world study by University of California, Irvine pharmacy researchers has found serious blood-related side effects associated with antibody-drug conjugates, an increasingly important class of targeted cancer therapies. ...
Jun 2, 2026
0
7
In an editorial published in the New England Journal of Medicine, University of Michigan Health hepatologist Anna S. Lok, M.D., hails newly announced results of the B-Well clinical trials as "a major step toward a functional ...
May 29, 2026
0
17
